All Type of News
Listed pharmas did well with operating activities in 1st quarter, but got weakened in profitability
Although listed pharmaceutical companies have recorded decent performances with business activities in the 1st quarter, their profitability was analyzed to be weakened for various reasons including non-operating losse...
Ildong’s chronic hepatitis B treatment ‘Besivo Tab’ become 28th Korean new drugIldong Pharmaceutical(CEO Woong-Sup Yoon) acquired approval of ‘Besivo Tab(generic name: besifovir dipivoxil maleat),’ a new chronic hepatitis B treatment developed by on its ow...
|
Korea Psoriasis Association ‘welcomes’ application of the exceptional health insurance benefits on severe psoriasis
The Korea Psoriasis Association(Chairman Sung-Ki Kim) gave a welcome to the Ministry of Health and Welfare’s decision on application of the exceptional health insurance benefits for severe psoriasis.
On the 25th of A...
JW Pharmaceutical acquires license of ‘emicizumab,’ innovative hemophilia A treatmentJW Pharmaceutical acquired a license of a hemophilia A treatment improved in administration convenience in Korea.
JW Pharmaceutical(CEO Sung-Kwon Han, Young-Seop Shin) announce...
|
MFDS changes status of medical narcotic monitoring from ‘regular to frequent’
The frequent onsite monitoring system will be operated as a measure to prevent misuse and abuse of medical narcotics, and the number of pharmaceutical products for the monitoring will be extended to 49 products.
The ...
Distribution companies to look for solutions by connecting online and offline services
Pharmaceutical distributors have shown actions to strengthen their sales and marketing power by connecting online and offline services to power through the difficult circumstances continuously caused by the government...
Which health-related proposals the new administration will take?
The pharmaceutical industry has paid sharp attention to the new administration’s policies and directions related to the pharmaceutical and biotechnology industry.
First of all, the pharmaceutical industry expects the...
Celltrion reveals Remsima clinical trial result on Crohn’s disease at DDW symposium
At the U.S. Digestive Disease Week(DDW) symposium at Chicago from the 6th to 9th of May, Celltrion revealed a result of the Remsima clinical trial(CT-P12 2.4 CD) on active Crohn’s disease patients and a result of the ...
KHIDI’s ‘Tailored Consulting Program’ for pharmaceutical and biotechnology fields
The Korea Health Industry Development Institute(KHIDI) announced on the 10th it will support consulting expenses for medium and small pharmaceutical companies on R&D planning, licensing, approval and marketing.
Appli...
2018 health insurance contribution negotiation starts, “We ask for reasonable contributions”
Today(10th), the new government will focus on the 2018 health insurance contribution negotiation starting with a meeting with the National Health Insurance Service(NHIS) and heads of healthcare-related orgazniations.
...
